Squarepoint’s C4 Therapeutics CCCC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$107K Sell
40,664
-95,390
-70% -$225K ﹤0.01% 4055
2025
Q4
$260K Buy
136,054
+125,955
+1,247% +$298K ﹤0.01% 3702
2025
Q3
$22.4K Sell
10,099
-133,588
-93% -$321K ﹤0.01% 4281
2025
Q2
$205K Buy
+143,687
New +$209K ﹤0.01% 3967
2024
Q4
Sell
-147,874
Closed -$843K 5048
2024
Q3
$843K Buy
147,874
+90,757
+159% +$546K ﹤0.01% 2729
2024
Q2
$264K Sell
57,117
-79,710
-58% -$475K ﹤0.01% 3503
2024
Q1
$1.12M Buy
136,827
+90,802
+197% +$704K ﹤0.01% 2509
2023
Q4
$260K Buy
+46,025
New +$105K ﹤0.01% 3447
2023
Q3
Sell
-52,024
Closed -$143K 3825
2023
Q2
$143K Sell
52,024
-55,608
-52% -$179K ﹤0.01% 3294
2023
Q1
$338K Buy
107,632
+52,911
+97% +$312K ﹤0.01% 2507
2022
Q4
$323K Buy
54,721
+33,467
+157% +$277K ﹤0.01% 2530
2022
Q3
$186K Sell
21,254
-15,344
-42% -$159K ﹤0.01% 2703
2022
Q2
$276K Buy
36,598
+20,519
+128% +$181K ﹤0.01% 2323
2022
Q1
$390K Buy
16,079
+3,078
+24% +$74.7K ﹤0.01% 2146
2021
Q4
$419K Buy
+13,001
New +$514K ﹤0.01% 2257

Other funds holding CCCC